Matthias Gratz

The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy.

U. Völker, S. Felix, R. Ewert, 2007, Cancer research.

VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION

H. Kroemer, I. Cascorbi, C. Fusch, 2005, Drug Metabolism and Disposition.

Nuclear factor-kappaB mediates up-regulation of cathepsin B by doxorubicin in tumor cells.

H. Kroemer, B. Sperker, J. Beck, 2004, Molecular pharmacology.